Skip to main content
Tags: johnson andjohnson | vaccine

CDC Advisory Panel: J&J Vaccine Benefits Outweigh Risks

CDC Advisory Panel: J&J Vaccine Benefits Outweigh Risks
(Sipa via AP)

Thursday, 22 July 2021 01:38 PM EDT

Even after reports of a neurological disorder in the six weeks after inoculation with Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh risks, according to an advisory panel of the U.S. Centers for Disease Control and Prevention.

Presentation slides posted Thursday, ahead of the Advisory Committee on Immunization Practices (ACIP) meeting showed that members of the ACIP's work group expressed "strong support" for continued use of J&J vaccine.

© 2024 Thomson/Reuters. All rights reserved.


Newsfront
Even after reports of a neurological disorder in the six weeks after inoculation with Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh risks, according to an advisory panel of the U.S. Centers for Disease Control and Prevention.
johnson andjohnson, vaccine
71
2021-38-22
Thursday, 22 July 2021 01:38 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved